Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

Share Price is delayed by 15 minutes
Get Live Data
84.00    1.00 (1.20%)
Bid:
82.00
Ask:
86.00
Spread: 4.00 (4.878%)
Market Cap: £87.84m
SDI Live PriceLast checked at - London Stock Exchange

Intraday SDI Group Share Chart

Trading Update

19 May 2025 07:00

RNS Number : 0996J
SDI Group PLC
19 May 2025
 

SDI Group plc

("SDI", the "Company", or the "Group")

Trading Update

19 May 2025 - SDI Group plc, the buy and build group, focused on companies which design and manufacture specialist lab equipment, industrial & scientific sensors and industrial & scientific products, provides a trading update for the year ended 30 April 2025 ("FY25").

The Company expects full year results to be in line with current market expectations1, following strong trading over the second half of FY25, offsetting the slow start to the financial year.

SDI has continued to demonstrate solid cash generation during FY25 and retains sufficient headroom within existing debt facilities to support the Group's acquisition strategy. At 30 April 2025 the Group had net debt of £13.8m and £9.9m of undrawn bank facility (excluding the £5m accordion option) and a further £0.6m of deferred consideration payable relating to previous acquisitions.

The Group has a robust order book, buoyed by an uptick in orders in Q4 FY25, and looks forward to providing a further update at the full year results in late-July/early August.

Operational Update

The Group strategy remains to drive growth organically as well as expanding the business through strategic acquisitions that complement the existing portfolio, where synergies including cross-sell opportunities can be leveraged.

Several businesses within the portfolio demonstrated strong performance in the second half. Monmouth Scientific experienced increased demand for its fume cabinets, while Safelab Systems successfully fulfilled a substantial order that had been deferred from the first half of the year. Chell saw increased demand for its DAQ product range, and Sentek benefited from positive market trends in pH sensors. Atik Cameras had an excellent FY25, with demand for its cameras normalising following a slow FY24, and both Graticules and MPB delivered strong overall performances across FY25.

Order intake increased during the second half of the year, driven by key contract wins across several businesses. These included a notable win for Atik Cameras from a professional astronomy customer, strong clean room order intake at Monmouth and a key agreement for Sentek with a prominent OEM. LTE Scientific and Applied Thermal Control both successfully launched new products and Sentek completed a successful trial of a novel pH sensor for a UK customer that is expected to produce a new revenue stream.

Over the course of FY25, the Group has acquired two businesses: InspecVision, a designer and manufacturer of computer vision-based measurement systems for industrial applications, acquired in October 2024, and Collins Walker, a designer and manufacturer of electric boilers, acquired in April 2025. InspecVision is trading as a standalone business within the portfolio, whilst the integration of Collins Walker into Applied Thermal Control has begun. InspecVision traded positively, as expected, post-acquisition. Due to the Collins Walker acquisition being completed in April 2025, as expected, it did not have a significant impact on FY25.

Post year end, InspecVision was awarded the prestigious King's Award for Enterprise in the category of International Trade, reflecting its quality as a successful and profitable UK engineering business operating in a unique, but critical, niche.

Tariffs

Approximately 10% of revenues in FY25 were generated from sales directly to the US, and the introduction of tariffs on products sold to the US is not expected to have a material impact on the Group.

Stephen Brown, CEO of SDI Group commented:

"The second half of the year has finished strongly, with momentum continuing into FY26. We are seeing some notable performances from businesses across our portfolio and good demand for their niche highly specialised scientific and industrial products, despite the global economic uncertainty. This is testament to the quality businesses within our portfolio and their diversified geographical and sectoral customer base."

1 Analysts from SDI's broker Cavendish Capital Markets Limited, and from Progressive Equity Research regularly provide research on the Company, accessible from SDI's website, and the Group considers the average of their forecasts to represent market expectations which for FY25 are Sales of £66.5m and Adjusted Profit Before Tax of £8.4m.

 

Enquiries:

SDI Group plc

Stephen Brown, Chief Executive Officer

Amitabh Sharma, Chief Financial Officer

+44 (0)1223 727144

www.sdigroup.com

 

Cavendish Capital Markets Ltd (NOMAD & broker)

Ed Frisby / Seamus Fricker - Corporate Finance

Andrew Burdis / Sunila de Silva - ECM

 

 

+44 (0)20 7220 0500

Vigo Consulting (Financial Communications)

Tim McCall / Rozi Morris / Fiona Hetherington

 

+44 (0)20 7390 0230

SDIGroup@vigoconsulting.com 

 

About SDI Group plc

SDI Group plc is a group of small to medium size companies with specialist industrial and scientific products in growth sector niches which help solve customers' key challenges. It specialises in the acquisition and development of companies that design and manufacture specialist products for use in lab equipment, industrial & scientific sensors and industrial & scientific products.

Its portfolio of businesses supplies the life sciences, healthcare, plastics and packaging, manufacturing, precision optics and measurement instrumentation markets.

SDI aims to continue its growth through driving the organic growth of its portfolio companies and by the acquisition of complementary technology businesses with established reputations in global markets.

For more information, please see: www.SDIGroup.com

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZZGMKNVZGKZM
Date   Source Headline
18th Mar 202412:49 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSDirector/PDMR Shareholding
8th Mar 20243:15 pmRNSHolding(s) in Company
26th Feb 20247:00 amRNSLong Term Incentive Plan Awards
23rd Feb 202411:00 amRNSHolding(s) in Company
21st Feb 20246:00 pmRNSDirector/PDMR Shareholding
20th Feb 20247:00 amRNSHolding(s) in Company
13th Feb 202411:14 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSDirectorate Change – Appointment of New CEO
8th Dec 20233:45 pmRNSHolding(s) in Company
8th Dec 20232:30 pmRNSHolding(s) in Company
7th Dec 20231:15 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSInterim Results
4th Dec 20237:00 amRNSNotice of Results and Investor Presentation
7th Nov 20234:10 pmRNSDirector/PDMR Shareholding
7th Nov 20233:50 pmRNSDirector/PDMR Shareholding and TVR - Replacement
7th Nov 20237:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
6th Nov 20237:00 amRNSAcquisition of Peak Sensors
31st Oct 20234:20 pmRNSHolding(s) in Company
26th Oct 20235:45 pmRNSHolding(s) in Company
29th Sep 202311:30 amRNSResult of AGM
29th Sep 20237:00 amRNSAGM Trading Update
24th Aug 20237:00 amRNSBoard Appointment
8th Aug 20237:00 amRNSFinal Results
2nd Aug 20237:00 amRNSNotice of Results and Investor Presentation
26th May 20231:40 pmRNSHolding(s) in Company
16th May 20232:55 pmRNSHolding(s) in Company
11th May 202311:50 amRNSDirector Dealing
11th May 20237:00 amRNSTrading Update
19th Apr 20231:00 pmRNSDirector/PDMR Shareholding and TVR
12th Apr 20235:15 pmRNSDirector/PDMR Shareholding
31st Mar 20233:45 pmRNSDirector Dealing
15th Mar 202312:00 pmRNSHolding(s) in Company
15th Feb 20235:30 pmRNSHolding(s) in Company
13th Feb 20233:55 pmRNSHolding(s) in Company
3rd Feb 20232:00 pmRNSExercise of Options and Total Voting Rights
1st Feb 202310:15 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBoard Appointment
5th Jan 202310:00 amRNSExercise of Options and Total Voting Rights
14th Dec 20224:00 pmRNSExercise of Options and Total Voting Rights
7th Dec 20227:00 amRNSInterim Results
7th Nov 20227:00 amRNSInvestor Presentation
3rd Nov 20227:00 amRNSNotice of Results
27th Oct 20223:55 pmRNSDirector Dealings, Exercise of Options and TVR
26th Oct 20227:00 amRNSLong Term Incentive Plan Awards
24th Oct 20227:00 amRNSAcquisition of Fraser Anti-Static Techniques Ltd
21st Sep 20224:15 pmRNSResult of AGM and Board Appointment
21st Sep 20227:00 amRNSAGM Trading Update
24th Aug 20227:00 amRNSPosting of Annual Report and Notice of AGM
1st Aug 20227:00 amRNSAcquisition of LTE Scientific Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.